Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis

Infection

Volumn 40, Issue 6, 2012, Pages 703-707

  Taj Aldeen, S J ^a   Falamarzi, A ^b   AlMuzrkchi, A ^b   Guarro, J ^c  

^a Department of Laboratory Medicine and Pathology ^*  (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Pediatric infection; Rhino orbital mucormycosis; Saksenaea vasiformis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; POSACONAZOLE;

ARTICLE; CASE REPORT; CELLULITIS; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ENDOSCOPIC SURGERY; EPIPHORA; ERYTHROCYTE SEDIMENTATION RATE; ETHMOIDECTOMY; EYE SWELLING; EYELID DISEASE; FLUORESCENCE MICROSCOPY; HEADACHE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MALE; MUCORALES; NASAL BIOPSY; NEUTROPHIL; NEUTROPHIL COUNT; NOSE DISEASE; NOSE INFECTION; ORBIT INFECTION; PRESCHOOL CHILD; RHINO ORBITAL INFECTION; SAKSENAEA VASIFORMIS; SPORANGIOSPORE; SPOROGENESIS; TREATMENT RESPONSE; VOMITING;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEBRIDEMENT; HUMANS; INFANT; MALE; MUCORALES; MUCORMYCOSIS; ORBITAL DISEASES; PARANASAL SINUS DISEASES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TRIAZOLES;

EID: 84874105287     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0338-2     Document Type: Article

References (24)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236-301.
2. Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia. 1976;68:52-62.
3. Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following waterrelated wound in a 24-year-old immunocompetent woman. Mycoses. 2009;52:547-9.
4. Baradkar VP, Kumar S. Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host. Indian J Dermatol. 2009;54:382-4.
5. Trotter DJ, Gonis G, Cottrill E, Coombs C. Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust. 2008;189:519-20.
6. Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis. 2000;30:942-3.
7. Baradkar VP, Mathur M, Taklikar S, Rathi M, Kumar S. Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India. Indian J Med Microbiol. 2008;26:385-7.
8. Kompoti M, Michalia M, Kallitsi G, Giannopoulou P, Arabatzis M, Liapi G, Velegraki A, Trikka-Graphakos E, Clouva-Molyvdas PM. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses. 2011;54:e599-601.
9. Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32:1823-4.
10. Gonis G, Starr M. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr Infect Dis J. 1997;16:714-6.
11. Vega W, Orellana M, Zaror L, Gené J, Guarro J. Saksenaea vasiformis infections: case report and literature review. Mycopathologia. 2006;162:289-94.
12. Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol. 2010;48:4410-6.
13. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-53.
14. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859-67.
15. Kaushik R, Chander J, Gupta S, Sharma R, Punia RS. Fatal primary cutaneous zygomycosis caused by Saksenaea vasiformis: case report and review of literature. Surg Infect (Larchmt). 2012;13:125-9.
16. Chander J, Kaur J, Attri A, Mohan H. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010;131:765-70.
17. Wilson PA. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med J Aust. 2008;189:521-2.
18. Lechevalier P, Hermoso DG, Carol A, Bonacorsi S, Ferkdadji L, Fitoussi F, Lortholary O, Bourrillon A, Faye A, Dannaoui E, Angoulvant F. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol. 2008;46:3169-72.
19. Blanchet D, Dannaoui E, Fior A, Huber F, Couppié P, Salhab N, Hoinard D, Aznar C. Saksenaea vasiformis infection, French Guiana. Emerg Infect Dis. 2008;14:342-4.
20. Padmaja IJ, Ramani TV, Kalyani S. Cutaneous zygomycosis: necrotising fascitis due to Saksenaea vasiformis. Indian J Med Microbiol. 2006;24:58-60.
21. Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Haematologica. 2005;90:ECR39.
22. Campelo C, de Miguel S, del Palacio A. Zigomicosis rinocerebral causada por Saksenaea vasiformis en un paciente diabetic. Enferm Infecc Microbiol Clin. 2005;23:77.
23. Kaufman L, Padhye AA, Parker S. Rhinocerebral zygomycosis caused by Saksenaea vasiformis. J Med Vet Mycol. 1988;26: 237-41.
24. Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2009;31:911-9.